![](https://bigul.co/stock-screener/assetData/img/bar-shape.png)
![](https://bigul.co/stock-screener/assetData/img/pointer.png)
Bullish Moving Averages
10
Bearish Moving Averages
6
Products
Investments
Back Stocks profile
Today’s low
39.00Today’s High
40.7052W low
24.4052W High
56.00Open Price
39.70Prev. Close
39.5700Volume
18784.00Value
758685.76Market Cap
60.20
Price to Earnings
23.80
Price to Book Value
1.10
Dividend Yield
0.00
PE to Growth
-5.10
Op Revenue TTM
45.45
Net Profit TTM
2.53
Cash From Operating Activity
15.52
Return on Equity %
4.64
EMA & SMA
Bullish Moving Averages
10
Bearish Moving Averages
6
DELIVERY AND VOLUME
05 Jul, 2024
Week
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
PIVOT
First Resistance
41.04
Second Resistance
41.68
Third Resistance
42.68
First Support
39.40
Second Support
38.40
Third Support
37.76
Relative Strength Index
48.36
Money Flow Index
47.37
MACD
-0.28
MACD Signal
-0.38
Average True Range
1.84
Average Directional Index
12.84
Rate of Change (21)
0.65
Rate of Change (125)
-17.66
Commodity Channel Index
-102.3
Williams %R
-72.9
BETA
1 Month
0.54
3 Month
0.36
1 Year
0.34
3 Year
0.3
PRICE CHANGE ANALYSIS
1 Week
Low
High
39.05
40.98
1 Month
Low
High
39
43.99
3 Months
Low
High
37.8
50.8
6 Months
Low
High
35.25
56
1 Year
Low
High
24.4
56
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 11.56 | 12.74 | 9.04 | 11.58 | 14.42 | 13.43 | 12.54 | 11.26 | 15.15 | 12.92 | 10.20 | |
Operating Expenses Qtr | 6.22 | 6.33 | 4.27 | 6.98 | 7.29 | 8.48 | 7.88 | 6.48 | 13.70 | 7.17 | 6.33 | |
Operating Profit Qtr | 5.33 | 6.38 | 4.78 | 4.60 | 7.11 | 4.94 | 4.66 | 4.78 | 1.61 | 5.75 | 3.84 | |
EBIDT Qtr Cr | 5.34 | 6.41 | 4.78 | 4.60 | 7.13 | 4.94 | 4.67 | 4.78 | 1.45 | 5.75 | 3.87 | |
Depreciation Qtr | 2.43 | 2.28 | 2.30 | 2.29 | 2.26 | 2.30 | 2.37 | 2.33 | 2.20 | 1.71 | 1.74 | |
Net Profit Qtr | 0.70 | 1.32 | 0.25 | 0.26 | 2.04 | 0.16 | 0.12 | 0.32 | -0.68 | 1.37 | 0.28 | |
Basic EPS Qtr | 0.47 | 0.89 | 0.16 | 0.17 | 1.37 | 0.11 | 0.08 | 0.22 | -0.48 | 0.97 | 0.20 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 44.92 | 51.66 | 51.48 | 51.85 | 55.41 | |
Operating Expenses Annual Cr | 23.80 | 30.14 | 35.58 | 34.11 | 42.88 | |
Operating Profit Annual | 21.08 | 21.49 | 15.82 | 17.66 | 12.47 | |
Operating Profit Margin Annual % | 46.94 | 41.59 | 30.72 | 34.07 | 22.51 | |
Total Expenses Annual Cr | 40.86 | 47.05 | 47.01 | 43.23 | 51.15 | |
EBIDT Annual Cr | 21.12 | 21.52 | 15.91 | 17.74 | 12.53 | |
EBIDT Annual margin % | 47.03 | 41.66 | 30.90 | 34.22 | 22.61 | |
Depreciation | 9.29 | 9.27 | 7.44 | 5.59 | 5.17 | |
PAT Before ExtraOrdinary Items Annual Cr | 2.52 | 2.63 | 2.20 | 5.68 | 4.44 | |
Net Profit Annual | 2.52 | 2.63 | 2.20 | 5.68 | 4.44 | |
Basic EPS Annual | 1.69 | 1.77 | 1.56 | 4.41 | 3.45 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 54.40 | 51.87 | 47.14 | 42.54 | 33.04 | |
Minority Interest Liability Annual Cr | - | - | - | - | - | |
Total Non Current Liabilities Annual Cr | 42.59 | 43.96 | 49.97 | 12.93 | 7.83 | |
Total Current Liabilities Annual Cr | 37.81 | 24.97 | 23.18 | 21.83 | 20.56 | |
Total Capital Plus Liabilities Annual Cr | 134.80 | 120.81 | 120.30 | 77.31 | 61.42 | |
Fixed Assets Annual | 86.23 | 87.41 | 92.68 | 49.01 | 31.78 | |
Total Non Current Assets Annual | 86.58 | 87.92 | 93.12 | 49.10 | 33.43 | |
Total Current Assets Annual | 48.22 | 32.88 | 27.18 | 28.21 | 27.99 | |
Total Assets Annual | 134.80 | 120.81 | 120.30 | 77.31 | 61.42 | |
Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 15.83 | 14.73 | 13.62 | 14.10 | 7.72 | |
Cash from Investing Activity Annual | -7.95 | -4.00 | -51.11 | -22.82 | -7.08 | |
Cash from Financing Annual Activity | -7.56 | -11.20 | 37.85 | 8.83 | -0.18 | |
Net Cash Flow Annual | - | -0.47 | 0.37 | 0.11 | 0.46 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 36.50 | 34.81 | 33.05 | 31.70 | 25.63 | |
ROE Annual % | 4.63 | 5.07 | 4.67 | 13.36 | 13.45 | |
ROCE Annual % | 12.19 | 12.78 | 8.71 | 21.90 | 17.99 | |
Total Debt to Total Equity Annual | 1.30 | 1.16 | 1.38 | 0.68 | 0.67 | |
EBDIT Annual Margin % | 47.06 | 41.69 | 30.95 | 34.26 | 22.62 |
Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Qtr Revenue cr | 11.77 | 12.88 | 9.26 | 11.58 | 14.78 | 13.54 | 12.68 | 11.26 | 15.15 | 12.92 | 10.20 | |
Operating Expenses Qtr | 6.39 | 6.47 | 4.40 | 7.10 | 7.63 | 8.61 | 8.01 | 6.48 | 13.70 | 7.17 | 6.33 | |
Operating Profit Qtr | 5.37 | 6.38 | 4.86 | 4.49 | 7.13 | 4.92 | 4.66 | 4.78 | 1.60 | 5.75 | 3.84 | |
EBIDT Qtr Cr | 5.38 | 6.41 | 4.86 | 4.49 | 7.15 | 4.93 | 4.67 | 4.78 | 1.45 | 5.75 | 3.87 | |
Depreciation Qtr | 2.43 | 2.28 | 2.30 | 2.29 | 2.26 | 2.30 | 2.37 | 2.33 | 2.21 | 1.71 | 1.74 | |
Net Profit Qtr | 0.74 | 1.32 | 0.33 | 0.14 | 2.06 | 0.15 | 0.12 | 0.32 | -0.69 | 1.37 | 0.28 | |
Basic EPS Qtr | 0.50 | 0.89 | 0.22 | 0.10 | 1.38 | 0.10 | 0.08 | 0.22 | -0.49 | 0.97 | 0.20 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total Revenue Annual | 45.49 | 52.27 | 51.49 | 51.85 | 55.41 | |
Operating Expenses Annual Cr | 24.36 | 30.73 | 35.58 | 34.11 | 42.88 | |
Operating Profit Annual | 21.09 | 21.50 | 15.81 | 17.66 | 12.47 | |
Operating Profit Margin Annual % | 46.36 | 41.14 | 30.71 | 34.06 | 22.51 | |
Total Expenses Annual Cr | 41.43 | 47.65 | 47.02 | 43.23 | 51.15 | |
EBIDT Annual Cr | 21.13 | 21.54 | 15.91 | 17.74 | 12.52 | |
EBIDT Annual margin % | 46.45 | 41.21 | 30.90 | 34.21 | 22.60 | |
Depreciation | 9.29 | 9.27 | 7.45 | 5.59 | 5.17 | |
PAT Before ExtraOrdinary Items Annual Cr | 2.53 | 2.65 | 2.20 | 5.68 | 4.44 | |
Net Profit Annual | 2.53 | 2.65 | 2.20 | 5.68 | 4.44 | |
Basic EPS Annual | 1.51 | 1.78 | 1.56 | 4.23 | 3.45 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Total ShareHolders Funds Annual | 54.40 | 51.87 | 47.14 | 42.53 | 33.02 | |
Minority Interest Liability Annual Cr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non Current Liabilities Annual Cr | 44.82 | 46.19 | 49.97 | 15.16 | 10.10 | |
Total Current Liabilities Annual Cr | 37.91 | 24.97 | 23.18 | 21.84 | 20.56 | |
Total Capital Plus Liabilities Annual Cr | 137.13 | 123.03 | 120.30 | 79.52 | 63.69 | |
Fixed Assets Annual | 89.59 | 90.77 | 92.68 | 52.37 | 35.14 | |
Total Non Current Assets Annual | 89.90 | 91.24 | 93.12 | 52.44 | 36.77 | |
Total Current Assets Annual | 47.23 | 31.79 | 27.18 | 27.09 | 26.92 | |
Total Assets Annual | 137.13 | 123.03 | 120.30 | 79.52 | 63.69 | |
Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Cash from Operating Activity Annual | 15.52 | 14.83 | 13.83 | 14.18 | 8.61 | |
Cash from Investing Activity Annual | -7.95 | -4.00 | -51.11 | -22.82 | -10.23 | |
Cash from Financing Annual Activity | -7.56 | -11.18 | 37.83 | 8.78 | 2.09 | |
Net Cash Flow Annual | - | -0.34 | 0.55 | 0.14 | 0.47 |
Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
---|---|---|---|---|---|---|
Book Value Per Share Annual | 36.50 | 34.81 | 33.05 | 31.69 | 25.62 | |
ROE Annual % | 4.64 | 5.10 | 4.66 | 13.36 | 13.44 | |
ROCE Annual % | 11.93 | 12.51 | 8.71 | 21.06 | 17.04 | |
Total Debt to Total Equity Annual | 1.34 | 1.20 | 1.38 | 0.73 | 0.74 | |
EBDIT Annual Margin % | 46.48 | 41.23 | 30.96 | 34.26 | 22.62 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
MAXCELL PHONES COMMUNICATIONS INDIA PRIVATE LIMITED | 8.05 | 74505499 | 0 | 33.33 |
Name | Holding Percent | Holding Id | Pledged % | Locked % |
---|---|---|---|---|
KOMPELLA MADHAVI LATHA | 1.68 | 74505494 | 0 | 0 |
KOMPELLA VISWANATH | 1.01 | 74505495 | 0 | 0 |
CRYPTOLOGIC SYSTEMS PRIVATE LIMITED | 9.02 | 74505498 | 0 | 0 |
MAXCELL PHONES COMMUNICATIONS INDIA PRIVATE LIMITED | 8.05 | 74505499 | 0 | 33.33 |
SHRI SHRI RESORTS PVT LTD | 7.16 | 74505500 | 0 | 93.72 |
IRAGAVARAPU CONSTRUCTIONS PRIVATE LIMITED | 6.71 | 74505501 | 0 | 40 |
IRON AGE INDIA LTD | 4.03 | 74505502 | 0 | 0 |
PKI SOLUTIONS PRIVATE LIMITED | 4.03 | 74505503 | 0 | 0 |
Name | Holding Percent | Holding Id |
---|
Name | Holding Percent | Holding Id |
---|---|---|
ANIL KUMAR PINAPALA | 1.74 | 74505514 |
MALLEMKONDA REALITIES PVT LTD | 5.89 | 74505509 |
EVERY WEAR IMPORT AND EXPORT PRIVATE LIMITED | 4.46 | 74505510 |
VEAN SMART INFRA PRIVATE LIMITED | 3.35 | 74505511 |
ELITE CLASS ASSET HOLDINGS LTD | 8.72 | 74505517 |
RITE EQUITY SDN BHD | 3.77 | 74505518 |
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
---|---|---|---|---|
Aug 08, 2002 | - | FINAL | - | Equity Share |
Ex-Date | Split Ratio | Record Date |
---|
Ex-Date | Purpose | Notes |
---|---|---|
May 20, 2024 | Audited Results | - |
Feb 12, 2024 | Quarterly Results | - |
Nov 14, 2023 | Quarterly Results | - |
Sep 21, 2023 | Preferential issue of shares | - |
Aug 07, 2023 | Quarterly Results | - |
May 30, 2023 | Audited Results | - |
Feb 13, 2023 | Quarterly Results | - |
Dec 21, 2022 | Preferential iIssue of shares | - |
Nov 14, 2022 | Quarterly Results | - |
Aug 10, 2022 | Quarterly Results | - |
May 30, 2022 | Audited Results | - |
Feb 02, 2022 | Quarterly Results | - |
Nov 02, 2021 | Quarterly Results | - |
Aug 28, 2021 | A.G.M. | - |
Aug 13, 2021 | Quarterly Results | - |
Jun 29, 2021 | Audited & Quarterly Results | - |
Feb 10, 2021 | Quarterly Results | - |
Nov 11, 2020 | Quarterly Results | - |
Aug 28, 2020 | Quarterly Results & Issue Of Warrants | - |
Jun 30, 2020 | Audited Results | - |
Feb 10, 2020 | Quarterly Results | - |
Nov 13, 2019 | Quarterly Results | - |
Aug 12, 2019 | Quarterly Results | - |
May 17, 2019 | Audited Results | - |
Feb 12, 2019 | Quarterly Results | - |
Nov 13, 2018 | Quarterly Results | - |
Aug 13, 2018 | Unaudited Financial Results | - |
May 28, 2018 | Audited Results | - |
Feb 14, 2018 | Quarterly Results | - |
Dec 07, 2017 | Quarterly Results | - |
Sep 13, 2017 | Quarterly Results | - |
May 19, 2017 | Audited Results | - |
Apr 26, 2017 | Others | Considered and approved appointment of Mrs. Vijaya Lakshmi Mantha as Additional Director of the Company. We are herewith enclosing her brief profile. |
Feb 10, 2017 | Quarterly Results | - |
Nov 11, 2016 | Quarterly Results | - |
Aug 31, 2016 | Others | To approve draft Director's Report for the financial year ending on March 31, 2016. |
Aug 11, 2016 | Quarterly Results | - |
May 27, 2016 | Audited Results | Interalia, have approved the Vivo Bio ESOP Scheme 2016 and notice of postal Ballot. |
Feb 11, 2016 | Quarterly Results | - |
Jan 11, 2016 | General Purpose | The Board approved the proposal to take on lease the building owned by M/s. Virinchi Technologies Ltd situated at Pothaipally Village, Hakimpet on such terms and conditions. |
Nov 13, 2015 | Quarterly Results | - |
Aug 31, 2015 | Others | 1. To fix Date, Time and Place of Annual General Meeting. 2. To approve appointment of Mr. N.V.S.S. Suryanarayana Rao, Company Secretary in Practice as Scrutinizer for conducting E-Voting. |
Aug 12, 2015 | Quarterly Results | - |
May 28, 2015 | Audited Results | - |
Nov 12, 2014 | Quarterly Results | - |
Aug 30, 2014 | Preferential Issue of shares | 1. To approve the notice for AGM, Directors' Reports and Management Discussion Analysis Report. 2. To consider preferential allotment of shares. 3. To fix Book Closure Dates. |
Aug 12, 2014 | Quarterly Results | - |
May 28, 2014 | Audited Results | - |
Feb 13, 2014 | Quarterly Results | - |
Nov 12, 2013 | Quarterly Results | - |
Aug 29, 2013 | Others | To consider preferential allotment of shares & to approve the notice of AGM, Directors Report. |
Aug 13, 2013 | Quarterly Results | - |
May 29, 2013 | Audited Results | - |
Feb 13, 2013 | Quarterly Results | - |
Aug 30, 2012 | Audited Results | - |
Aug 10, 2012 | Quarterly Results | - |
May 12, 2012 | Quarterly Results | - |
Feb 10, 2012 | Quarterly Results | - |
Nov 12, 2011 | Quarterly Results | - |
Sep 01, 2011 | Audited Results | - |
Aug 06, 2011 | Quarterly Results | - |
May 13, 2011 | Quarterly Results | - |
Dec 24, 2010 | Restructuring of the Company | To discuss on the proposal of restructuring of the Company under section 293(1) (a) and also to approve the draft postal ballot notice. |
Aug 31, 2010 | Allotment of Warrants & Others | The Board has approved the allotment of 4,50,000 Warrants on pref. basis to Promoters & 10,00,000 Warrants to Strategic Investors & Convened the 23rd AGM of the Co. will be held on Sept 29, 2010. |
Jul 31, 2010 | Quarterly Results | - |
Jul 22, 2010 | Appointment of Additional Director | The Board has appointed Mr. Kalyan Sri Kompella as Additional Director on the Board. |
Jan 30, 2010 | Quarterly Results | - |
Oct 31, 2009 | Quarterly Results, Stock Split & Others | To consider raising of funds through issue of pref. allotment of Shares, to approve the change of registered office & to approve the amalgamation of M/s. Shri Shri Resorts Pvt. Ltd. with the Co. |
Aug 31, 2009 | Audited Results & Amalgamation | To consider the proposal of amalgamation of an unlisted Company with the Company & to approve the Balance Sheets, P & L, Directors report, Auditors report and Notes to accounts. |
Jul 31, 2009 | Quarterly Results | - |
Apr 25, 2009 | Quarterly Results | - |
Mar 06, 2009 | To appoint Additional Director | inter alia, to appoint Mr. K Jagan Mohan Rao as Additional Director w.e.f. March 05, 2009. |
Jan 31, 2009 | Quarterly Results | - |
Oct 31, 2008 | Quarterly Results | - |
Aug 30, 2008 | Audited Results | - |
Jul 31, 2008 | Quarterly Results | - |
Apr 30, 2008 | Quarterly Results | - |
Jan 30, 2008 | Quarterly Results | - |
Oct 31, 2007 | Quarterly Results | - |
Aug 28, 2007 | Audited Results | - |
Jul 31, 2007 | Quarterly Results | - |
Apr 30, 2007 | Quarterly Results | - |
Jan 31, 2007 | Quarterly Results | - |
Oct 31, 2006 | Quarterly Results | - |
Aug 31, 2006 | Accounts | - |
Jul 29, 2006 | Quarterly Results | - |
Apr 29, 2006 | Quarterly Results | - |
Jan 30, 2006 | Quarterly Results | - |
Jan 12, 2006 | Allotment of Shares | Allotted shares under preferential basis to selective investors & allotted warrants to promoters. |
Nov 22, 2005 | To consider enhancement of Capital | To consider enhancement of Capital & to consider opening up of branches in US, Canada & Singapore. |
Oct 26, 2005 | Quarterly Results | - |
Sep 21, 2005 | To consider fixing of the Record Date | - |
Jul 22, 2005 | Quarterly Results | - |
Apr 25, 2005 | Quarterly Results | - |
Jan 29, 2005 | Quarterly Results | - |
Oct 23, 2004 | Quarterly Results & Others | Amalgamation (Approved the draft scheme of merger for amalgamation of Silivo Protein Ltd., with the company) & Reduction of Capital |
Aug 16, 2004 | Accounts & General | - |
Jul 30, 2004 | Quarterly Results | - |
Apr 30, 2004 | Quarterly Results | - |
Jan 30, 2004 | Quarterly Results | - |
Nov 29, 2003 | Others | To consider to change the name of the Company and shifting of registered office. |
Oct 28, 2003 | Quarterly Results | - |
Jul 29, 2003 | Quarterly Results | - |
Apr 29, 2003 | Quarterly Results | - |
Jan 27, 2003 | Quarterly Results | - |
Oct 28, 2002 | Quarterly Results | - |
Jul 12, 2002 | Quarterly Results | - |
Apr 29, 2002 | Quarterly Results | - |
Jan 30, 2002 | Quarterly Results | - |
Oct 20, 2001 | Quarterly Results | - |
Jul 28, 2001 | Quarterly Results | - |
Apr 30, 2001 | Quarterly Results | - |
Jan 30, 2001 | Quarterly Results | - |
Oct 30, 2000 | Quarterly Results | - |
Jul 31, 2000 | Quarterly Results | - |
Apr 29, 2000 | Quarterly Results | - |
Nov 27, 1997 | Half Yearly Results | - |
May 30, 1997 | Half Yearly Results | - |
Ex-Date | Bonus Ratio | Record Date |
---|
VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Please find enclosed intimation regarding closure of trading window.VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed newspaper publication regarding dispatch of postal ballot notice.VIVO BIO TECH LTD. - 511509 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed the Notice of Postal Ballot for approval of the Members for appointment of Mr. Viswanath Kompella, Promoter, as an advisor of the Company.VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Outcome Of Board Meeting - Appointment Of Mr. Viswanath Kompella, Promoter, As An Advisor Of The Company
With reference to the above cited subject, and pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, ('Listing Regulations'), and based on the recommendation of the Audit Committee, the Board of Directors of the Company at their meeting held today, i.e. Tuesday, June 18, 2024, inter-alia, transacted the following business: 1. Approved the Notice of Postal Ballot recommending to the shareholders, for appointment of Mr. Viswanath Kompella, Promoter, as an advisor of the company. This is for your information and records.VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed newspaper advertisement for the Audited Financial Results for the quarter and year ended March 31, 2024.VIVO BIO TECH LTD. - 511509 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Please find enclosed Annual Secretarial Compliance Report for the year ended March 31, 2024VIVO BIO TECH LTD. - 511509 - Results - Audited Standalone And Consolidated Financial Results For The Fourth Quarter And Year Ended March 31, 2024
With reference to above mentioned subject, we bring to your kind notice that the Board of DIrectors of the Company at their meeting held today i.e., May 20, 2024, inter-alia, considered and approved the Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended March 31, 2024.VIVO BIO TECH LTD. - 511509 - Board Meeting Outcome for Meeting Convened On May 20, 2024
With reference to above cited subject, we bring to your kind notice that the Board of Directors at their meeting held today i.e., Monday, May 20, 2024, inter-alia, Approved the Audited Standalone and Consolidated Financial Results of the company for the fourth quarter and year ended March 31, 2024.VIVO BIO TECH LTD. - 511509 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed information regarding issuance of letter of confirmation(s) in lieu of the share certificate(s) lostVIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Quarter And Year Ended March 31, 2024.
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2024 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2024.The latest market price of Vivo Bio Tech Ltd. on NSE was Rs. 40.39 as of today.
The opening share price of Vivo Bio Tech Ltd. was Rs. 39.70 as of today.
The 52-week high share price of Vivo Bio Tech Ltd. was Rs. 56.00.
The 52 week low share price of Vivo Bio Tech Ltd. was Rs. 24.40.
The PE ratio of Vivo Bio Tech Ltd. is -5.10. Please refer to the Fundamentals section for further details.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.
Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.
Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.
Please refer to the News section for the latest news about Vivo Bio Tech Ltd..